Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gupta

Showing results (801-810 of 834) with videos related to

Pageof 84
Sort By:
Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.
Lancet (London, England)|April 18, 2015
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trialPeter Hillmen, Tadeusz Robak, Ann Janssens, et al.
British Journal of Anaesthesia|July 17, 2021
Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysisJames G Connolly, Joseph R Scarpa, Hersh V Gupta, et al.
British Journal of Anaesthesia|June 20, 2021
Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinomaJames G Connolly, Kay See Tan, Brooke Mastrogiacomo, et al.
BMC Medicine|January 1, 2020
Travel time to health facilities in areas of outbreak potential: maps for guiding local preparedness and responseE N Hulland, K E Wiens, S Shirude, et al.
Blood|June 29, 2012
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolEmilia Mahoney, David M Lucas, Sneha V Gupta, et al.
Bone Marrow Transplantation|October 12, 2011
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisH J Khoury, M Kukreja, J M Goldman, et al.
Viruses|April 23, 2022
Novel Compound Inhibitors of HIV-1<sub>NL4-3</sub> VpuCarolyn A Robinson, Terri D Lyddon, Hwi Min Gil, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
Pageof 84

Showing results (801-810 of 834) with videos related to

Sort By:
Pageof 84
Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.
Lancet (London, England)|April 18, 2015
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trialPeter Hillmen, Tadeusz Robak, Ann Janssens, et al.
British Journal of Anaesthesia|July 17, 2021
Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysisJames G Connolly, Joseph R Scarpa, Hersh V Gupta, et al.
British Journal of Anaesthesia|June 20, 2021
Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinomaJames G Connolly, Kay See Tan, Brooke Mastrogiacomo, et al.
BMC Medicine|January 1, 2020
Travel time to health facilities in areas of outbreak potential: maps for guiding local preparedness and responseE N Hulland, K E Wiens, S Shirude, et al.
Blood|June 29, 2012
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolEmilia Mahoney, David M Lucas, Sneha V Gupta, et al.
Bone Marrow Transplantation|October 12, 2011
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisH J Khoury, M Kukreja, J M Goldman, et al.
Viruses|April 23, 2022
Novel Compound Inhibitors of HIV-1<sub>NL4-3</sub> VpuCarolyn A Robinson, Terri D Lyddon, Hwi Min Gil, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
Pageof 84